Flibanserin

The new drug Flibanserin, being sold as Addyi, is now available for women – premenopausal women – who experience low sexual desire. The battle for FDA approval was a heated one, fraught with misconceptions, huge outpourings of money from Sprout Pharmaceuticals, and cries of gender bias in the FDA approval process. Addyi is not a …

As a practicing GYN in New York City, I am getting a lot of calls lately from my predominantly perimenopausal and menopausal patients, asking whether they are candidates for Flibanserin (ADDYI™). Whenever a new drug comes along, I am always cautious about prescribing it, until I feel certain that I understand all the benefits and …